Woods Lori A

CIK 00013930071 companySEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001393007

Recent Transactions

50 trades

Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2025-03-31$2.13/sh+23,475→ 183,460 total
Award
Perspective Therapeutics, Inc.$CATX
Stock option (right to buy)
2025-03-03+50,000→ 50,000 total
Award
Perspective Therapeutics, Inc.$CATX
Stock option (right to buy)
2024-06-20+23,000→ 23,000 total
Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2024-06-14$10.80/sh+83→ 159,985 total
Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2024-06-14$10.90/sh+4,504→ 159,902 total
Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2024-06-03$1.46/sh+34,246→ 1,553,984 total
Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2023-12-15$0.27/sh+152,962→ 1,519,738 total
Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2023-12-14$0.27/sh+32,238→ 1,366,776 total
Award
Perspective Therapeutics, Inc.$CATX
Stock Options (right to buy)
2023-12-12+230,000→ 2,412,500 total
Exercise/Conversion
Perspective Therapeutics, Inc.$CATX
Stock Options (right to buy)
2023-04-17−23,566→ 0 total
Exercise/Conversion
Perspective Therapeutics, Inc.$CATX
Common Stock
2023-04-17$0.61/sh+23,566→ 1,334,538 total
Exercise/Conversion
Perspective Therapeutics, Inc.$CATX
Common Stock
2023-04-13$0.61/sh+163,934→ 1,310,972 total
Exercise/Conversion
Perspective Therapeutics, Inc.$CATX
Stock Options (right to buy)
2023-04-13−163,934→ 0 total
Award
Perspective Therapeutics, Inc.$CATX
Stock Options (right to buy)
2023-02-21+470,000→ 2,140,000 total
Award
Perspective Therapeutics, Inc.$CATX
Stock Options (right to buy)
2023-02-21+230,000→ 2,370,000 total
Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2022-11-15$0.34/sh+100,000→ 1,147,038 total
Award
Perspective Therapeutics, Inc.$CATX
Stock Options (right to buy)
2022-07-21+940,000→ 1,670,000 total
Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2022-06-07$0.30/sh+75,000→ 1,047,038 total
Exercise/Conversion
Perspective Therapeutics, Inc.$CATX
Common Stock
2021-11-23$0.43/sh+62,500→ 972,038 total
Exercise/Conversion
Perspective Therapeutics, Inc.$CATX
Common Stock
2021-11-23$0.46/sh+62,500→ 909,538 total
Exercise/Conversion
Perspective Therapeutics, Inc.$CATX
Stock Options (right to buy)
2021-11-23−62,500→ 62,500 total
Exercise/Conversion
Perspective Therapeutics, Inc.$CATX
Stock Options (right to buy)
2021-11-23−62,500→ 0 total
Award
Perspective Therapeutics, Inc.$CATX
Stock Options (right to buy)
2021-07-01+480,000→ 855,000 total
Exercise/Conversion
Perspective Therapeutics, Inc.$CATX
Common Stock
2021-03-12$0.60/sh+25,000→ 635,500 total
Exercise/Conversion
Perspective Therapeutics, Inc.$CATX
Common Stock
2021-03-12$0.43/sh+62,500→ 760,500 total
Exercise of In-Money
Perspective Therapeutics, Inc.$CATX
Warrant (right to buy)
2021-03-12−24,038→ 0 total
Exercise/Conversion
Perspective Therapeutics, Inc.$CATX
Common Stock
2021-03-12$0.61/sh+62,500→ 823,000 total
Exercise of In-Money
Perspective Therapeutics, Inc.$CATX
Common Stock
2021-03-12$0.57/sh+24,038→ 847,038 total
Exercise/Conversion
Perspective Therapeutics, Inc.$CATX
Stock Options (right to buy)
2021-03-12−62,500→ 62,500 total
Exercise/Conversion
Perspective Therapeutics, Inc.$CATX
Stock Options (right to buy)
2021-03-12−62,500→ 187,500 total
Exercise/Conversion
Perspective Therapeutics, Inc.$CATX
Stock Options (right to buy)
2021-03-12−62,500→ 125,000 total
Exercise/Conversion
Perspective Therapeutics, Inc.$CATX
Stock Options (right to buy)
2021-03-12−25,000→ 0 total
Exercise/Conversion
Perspective Therapeutics, Inc.$CATX
Common Stock
2021-03-12$0.46/sh+62,500→ 698,000 total
Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2020-11-30$0.38/sh+68,000→ 610,500 total
Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2020-10-22$0.52/sh+48,076→ 48,076 total
Purchase
Perspective Therapeutics, Inc.$CATX
Warrant (right to buy)
2020-10-22+24,038→ 611,538 total
Award
Perspective Therapeutics, Inc.$CATX
Stock Options (right to buy)
2020-06-23+250,000→ 587,500 total
Exercise/Conversion
Perspective Therapeutics, Inc.$CATX
Stock Options (right to buy)
2020-02-03−125,000→ 125,000 total
Exercise/Conversion
Perspective Therapeutics, Inc.$CATX
Common Stock
2020-02-03$0.60/sh+75,000→ 355,000 total
Exercise/Conversion
Perspective Therapeutics, Inc.$CATX
Common Stock
2020-02-03$0.43/sh+62,500→ 542,500 total
Exercise/Conversion
Perspective Therapeutics, Inc.$CATX
Common Stock
2020-02-03$0.46/sh+125,000→ 480,000 total
Exercise/Conversion
Perspective Therapeutics, Inc.$CATX
Stock Options (right to buy)
2020-02-03−75,000→ 25,000 total
Exercise/Conversion
Perspective Therapeutics, Inc.$CATX
Stock Options (right to buy)
2020-02-03−62,500→ 187,500 total
Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2019-11-15$0.39/sh+25,000→ 280,000 total
Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2019-11-14$0.40/sh+125,000→ 255,000 total
Award
Perspective Therapeutics, Inc.$CATX
Stock Options (right to buy)
2019-06-18+250,000→ 600,000 total
Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2018-11-15$0.40/sh+635→ 130,000 total
Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2018-11-15$0.40/sh+4,365→ 129,365 total
Purchase
Perspective Therapeutics, Inc.$CATX
Common Stock
2018-11-14$0.40/sh+125,000→ 125,000 total
Award
Perspective Therapeutics, Inc.$CATX
Stock Options (right to buy)
2018-06-13+250,000→ 350,000 total

Companies

Perspective Therapeutics, Inc.
Director
$CATX

Recent Filings

Address

C/O PERSPECTIVE THERAPEUTICS, INC. 2401 ELLIOTT AVENUE, SUITE 320

SEATTLE, WA, 98121

View on SEC.gov